One-third of cannabis-induced psychosis cases later develop schizophrenia
A meta-analysis of 50 studies found that 34% of people with cannabis-induced psychosis eventually transitioned to schizophrenia, the highest rate among all substances.
Quick Facts
What This Study Found
Across 50 studies encompassing 40,783 people, the pooled transition rate from substance-induced psychosis to schizophrenia was 25%. Cannabis had the highest substance-specific transition rate at 34% (95% CI 25-46%), followed by hallucinogens (26%) and amphetamines (22%). Alcohol (10%), opioids (12%), and sedatives (9%) had much lower rates.
Key Numbers
50 studies; 40,783 people; overall transition 25%; cannabis 34% (6 studies); hallucinogens 26% (3 studies); amphetamines 22% (5 studies); alcohol 10%; opioids 12%; sedatives 9%.
How They Did This
Systematic review and meta-analysis of 50 studies from MEDLINE, PsychINFO, and Embase providing 79 estimates of transition from substance-induced psychosis to schizophrenia, including 43 substance-specific estimates.
Why This Research Matters
This establishes that cannabis-induced psychosis is not just a temporary drug reaction. One in three affected individuals will develop schizophrenia, making it the substance most strongly associated with psychosis transition.
The Bigger Picture
This meta-analysis reframes cannabis-induced psychosis as a potential prodrome of schizophrenia rather than a benign, self-limited drug reaction. It argues for assertive psychiatric follow-up in anyone experiencing cannabis-related psychosis.
What This Study Doesn't Tell Us
Heterogeneity in how substance-induced psychosis was defined across studies; transition rates may reflect shared vulnerability rather than causation; older cohorts had slightly lower rates; publication bias possible.
Questions This Raises
- ?Can we identify which cannabis-induced psychosis patients will transition?
- ?Would early antipsychotic treatment after cannabis-induced psychosis prevent progression?
Trust & Context
- Key Stat:
- 34% transition from cannabis-induced psychosis to schizophrenia
- Evidence Grade:
- Strong: large meta-analysis with 50 studies, robust methodology, and clear substance-specific comparisons.
- Study Age:
- Published 2020.
- Original Title:
- Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis.
- Published In:
- Schizophrenia bulletin, 46(3), 505-516 (2020)
- Authors:
- Murrie, Benjamin, Lappin, Julia(2), Large, Matthew(2), Sara, Grant
- Database ID:
- RTHC-02739
Evidence Hierarchy
Combines results from multiple studies to find an overall pattern.
What do these levels mean? →Frequently Asked Questions
Is cannabis-induced psychosis always temporary?
No. This meta-analysis found that 34% of people who experienced cannabis-induced psychosis eventually developed schizophrenia, making assertive psychiatric follow-up essential.
Which substances carry the highest risk of progressing to schizophrenia?
Cannabis had the highest transition rate (34%), followed by hallucinogens (26%) and amphetamines (22%). Alcohol (10%) and opioids (12%) had much lower rates.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-02739APA
Murrie, Benjamin; Lappin, Julia; Large, Matthew; Sara, Grant. (2020). Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis.. Schizophrenia bulletin, 46(3), 505-516. https://doi.org/10.1093/schbul/sbz102
MLA
Murrie, Benjamin, et al. "Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis.." Schizophrenia bulletin, 2020. https://doi.org/10.1093/schbul/sbz102
RethinkTHC
RethinkTHC Research Database. "Transition of Substance-Induced, Brief, and Atypical Psychos..." RTHC-02739. Retrieved from https://rethinkthc.com/research/murrie-2020-transition-of-substanceinduced-brief
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.